28 July 2025

Six things we learned about health innovation at Imperial Collider 2025

13 July 2025

DNA’s hidden shape reveals target to reverse ovarian cancer chemoresistance

07 May 2025

New flexible hepatitis C treatment options could help elimination efforts

16 December 2024

UK Researchers Awarded £6.4M Grant to Study Protein Dynamics and Cell Health

04 December 2024

Imperial spinout Siftr Bio aims to improve precision of ADC cancer drugs

07 November 2024

Exploring Molecular Glues: Insights from the Sir Geoffrey Wilkinson Lecture

19 September 2024

Institute for Molecular Science and Engineering (IMSE) Research Showcase 2024

01 August 2024

New tool could transform study of cells and help find new drug targets

08 July 2024

Imperial and Crick cancer drug spinout raises £90m to begin clinical development

13 June 2024

Mathematics PhD student wins major science communication competition

01 April 2024

New synthesis platform allows for rapid cancer drug synthesis and testing

26 March 2024

Eight things we learned about commercialising medical research at AYCI 2024

07 March 2024

Impact of artificial intelligence on AMR: Common themes and challenges

11 January 2024

New class of cancer and immunology drug targets mapped with new tagging system

27 November 2023

Unraveling the Secrets of Zombie cells

16 November 2023

UK approves world-first gene-editing treatment for blood disorders

31 October 2023

New £28m Centre to forge the next generation of AI digital healthcare innovators

20 October 2023

Towards using quantum computing to speed up drug development

19 October 2023

New mechanism found that maintains water balance within cells

13 October 2023

Imperial President - College making big moves to accelerate medical innovation

06 September 2023

Apollo Therapeutics raises $226.5m to develop medicines based on uni research

21 August 2023

Nobel-winning bodily ‘pressure sensors’ filmed for first time at Imperial

20 July 2023

New database of drug targets will help fight incurable diseases

23 May 2023

Imperial and Agilent renew partnership for flagship analytical science facility

22 May 2023

New partnership will use molecular glues to tackle ‘undruggable’ disease targets

21 February 2023

Research shows how human cells are protected when the immune system switches on

20 February 2023

UV-light activated probe finds new interactions in living cells

14 February 2023

Professor Ed Tate appointed to the GSK Chair in Chemical Biology

22 January 2023

Wearable tech, AI and clinical teams join to change the face of trial monitoring

16 December 2022

Innovation and entrepreneurship at Imperial: A year in review

02 November 2022

CRISPR-based oligo recombineering in drug discovery

21 October 2022

Observing the early universe and supporting net-zero: News from the College

20 September 2022

Epigenetic treatment in mice improves spinal cord regeneration after injury

17 August 2022

Imperial startup GlioQuell has the power to shut down cancer cells

01 July 2022

New device could accelerate the development of T-cell immunotherapies for cancer

27 June 2022

Intermittent fasting may help heal nerve damage

18 February 2022

New treatment could boost radiotherapy effectiveness for brain tumour patients

18 February 2022

AI for life sciences research gets boost from the financial markets

01 February 2022

Identification of the first covalent ligands of the small GTPase Rab27A

21 December 2021

Structure, mechanism, and inhibition of Hedgehog Acyltransferase

20 December 2021

New cross-disciplinary Collaborations Address Societal Challenges

30 November 2021

Poster prize awarded at RSC/SCI symposium on AMR

25 November 2021

Imperial awarded Queen’s Anniversary Prize for COVID-19 response

19 October 2021

Accelerated development of a potential treatment for cystic fibrosis

01 August 2021

Aug 2021 - Article Published in Trends in Chemistry

17 June 2021

Imperial partner Apollo receives £100m to boost medical research at leading unis

09 June 2021

Podcast explores new frontiers in analytical science

28 May 2021

Key enzyme aggravates colorectal cancer in obese patients

27 April 2021

New study reveals weak spots in chemotherapy-resistant cancer cells

07 April 2021

Cancer drugs could be delivered in molecular cages unlocked by light

23 February 2021

ADC Therapeutics to develop anti-cancer drugs in new White City Campus centre

04 February 2021

Imperial staff reflect on a challenging year – and their hopes for the future

30 November 2020

Imperial set to lead UK trial of innovative new cancer drug

16 November 2020

Imperial startup wins £4.5m investment to develop new cancer drugs

13 November 2020

Molecular insights into key drug target could help to enhance cancer treatments

12 November 2020

New anti-cancer drug combo treatment shows promise for myeloma patients

07 October 2020

Cancer-causing HTLV-1 virus hijacks cellular machinery to establish infection

06 October 2020

Agilent Measurement Suite celebrates early successes

15 September 2020

Potential therapeutic targets for cancer-causing virus uncovered by new research

23 July 2020

New way to tackle disease-causing proteins wins €20k in innovation competition

06 May 2020

Bacteria ‘factories’ used to discover potential new malaria drugs

08 April 2020

Four ways Imperial is leading the fight against Parkinson’s

08 April 2020

New COVID-19 project will use the power of smartphones to search for treatments

15 January 2020

Imperial physicist and chemist honoured in premier young scientist awards

06 January 2020

Cell ‘hands’ to unlock doors in health research, drug design, and bioengineering

21 October 2019

Researchers identify a new way to target treatment-resistant cancers

03 September 2019

Cholesterol-cutting gene silencing treatment shows lasting effects

24 May 2019

Developing a vaccine revolution: Imperial experts take on global epidemics

09 May 2019

Smart design could prevent drug resistance in new malaria treatments

20 March 2019

ICB CDT student awarded BBSRC Flexible Talent Mobility Innovation Placement

15 March 2019

Researchers offered ‘quick and easy’ grants to get medical innovations started

04 February 2019

Hit snooze to support World Cancer Day

15 January 2019

Elephantiasis and river blindness could be eliminated faster with new molecule

19 December 2018

Imperial and Bayer to accelerate drug discovery for heart conditions using AI

11 December 2018

Breast cancer drug could create chink in the armour of pancreatic cancer

03 December 2018

Dr Anna Barnard awarded prestigious Sir Henry Dale fellowship

17 October 2018

Expert to help improve drugs for patients and environment with Academy Chair

08 October 2018

Breakthrough drug shows early promise for multiple myeloma

13 September 2018

What happens when our cells stop cleaning up after themselves?

03 September 2018

Big data approach to drug discovery leads to new epilepsy target

31 May 2018

WHO World No Tobacco Day: why the key to quitting smoking could lie in our guts

14 May 2018

Molecule that acts on human cells might provide hope for irresistible cold cure

01 May 2018

Tuneable genetic ‘clocks’ might lead to improved biotech strategies

19 April 2018

Revealing the hidden biotech potential of unexplored organisms

10 April 2018

New class of drugs could help tackle treatment-resistant cancers

14 March 2018

New class of menopause drugs reduces severity of hot flushes in three days

10 January 2018

Imperial partners with Heptares to search for new gut drugs

12 December 2017

A gene therapy treatment for Haemophilia could help lead the way to a cure

06 September 2017

Statins reduce deaths from heart disease by 28 per cent, says longest ever study

06 September 2017

Scientists link 153 new genetic variants to osteoporosis in largest ever study

16 August 2017

'Twinkling' enzymes could light the way to better cancer drugs

07 August 2017

New antibiotic that kills gonorrhoea in the lab could help curb 'superbug' trend

12 July 2017

Targeting 'broken' metabolism in immune cells reduces inflammatory disease

05 July 2017

Imperial partners with AstraZeneca to fund basic research

20 June 2017

Unlock molecular secrets with mobile game BioBlox2D

19 June 2017

Imperial infection team wins GSK challenge to develop medicines of the future